Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: NIH Grants Awarded to MD Anderson, Johns Hopkins, Scripps, and More


NIH Grants in Proteomics, February 8 to March 14

Project Title: Markers for HCV-Related HCC: Plasma Profiling, Targeted Strategies and Validation
Contact Principal Investigator: Laura Beretta
Organization Name: University of Texas MD Anderson Cancer Center
Project Start Date: May 1, 2009
Project End Date: : Feb. 28, 2014
FY Total Cost: $144,918

Project Title: Translational Proteomics: Biology, Technology and Clinical Advances
Contact Principal Investigator: Daniel Wanyui Chan
Organization Name: Johns Hopkins University
Project Start Date: March 5, 2013
Project End Date: : Feb. 28, 2014
FY Total Cost: $20,000

Project Title: Chemical Approaches for Activity-based Proteomics
Contact Principal Investigator: Benjamin Cravatt
Organization Name: Scripps Research Institute
Project Start Date: July 1, 2000
Project End Date: : Feb. 28, 2014
FY Total Cost: $141,434

Project Title: Identification of Proteins from Mass Spectrometry Data: A Statistical Approach
Contact Principal Investigator: Susmita Datta
Organization Name: University of Louisville
Project Start Date: March 4, 2012
Project End Date: : March 31, 2016
FY Total Cost: $350,760

Project Title: Protein Biomarkers for Invasive Aspergillosis Diagnostics
Contact Principal Investigator: Marta Feldmesser
Organization Name: Albert Einstein College of Medicine Yeshiva University
Project Start Date: Jan. 1, 2010
Project End Date: : Feb. 28, 2015
FY Total Cost: $442,921

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.